In Treatment of Type 2 diabetes mellitus M Forlin 1000mg Tablet SR belongs to a class of medicines called biguanides. It works by lowering glucose production in the liver, delaying the absorption of sugar (glucose) from the intestines, and increasing the body's sensitivity to insulin. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
It is unsafe to consume alcohol with M Forlin 1000mg Tablet SR.
M Forlin 1000mg Tablet SR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
M Forlin 1000mg Tablet SR should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
M Forlin 1000mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of M Forlin 1000mg Tablet SR may be needed. Please consult your doctor. Use of M Forlin 1000mg Tablet SR is, however, not recommended in patients with severe kidney disease.
M Forlin 1000mg Tablet SR is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
If you miss a dose of M Forlin 1000mg Tablet SR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Univentis Medicare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Eris Lifesciences Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Wockhardt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Anthus Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neelkanth Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vidakem Lifesciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Knoll Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cadbless Life Care || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Caligen Labs Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Duken Pharmaceuticals || ₹14.5/tablet (25% cheaper)